Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Comparative Efficacy Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Subjects With Acute Bacterial Exacerbation of Chronic Bronchitis.

NCT00645086 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00645086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00645086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Comparative Efficacy Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Subjects With Acute Bacterial Exacerbation of Chronic Bronchitis.
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2002
Completion date
Not reported
Enrollment
465 (actual)
Sites
146

Conditions

As the registry lists them; a condition with its own page is linked.

acute bacterial exacerbation of chronic bronchitis (abecb).